JPS61246130A - 水性皮膚及び毛髪化粧料 - Google Patents
水性皮膚及び毛髪化粧料Info
- Publication number
- JPS61246130A JPS61246130A JP60087988A JP8798885A JPS61246130A JP S61246130 A JPS61246130 A JP S61246130A JP 60087988 A JP60087988 A JP 60087988A JP 8798885 A JP8798885 A JP 8798885A JP S61246130 A JPS61246130 A JP S61246130A
- Authority
- JP
- Japan
- Prior art keywords
- water
- plasma
- skin
- cell activity
- skin cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000694 effects Effects 0.000 title claims abstract description 16
- 210000004927 skin cell Anatomy 0.000 title claims abstract description 13
- 230000000638 stimulation Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 239000008346 aqueous phase Substances 0.000 claims abstract description 8
- 229910017053 inorganic salt Inorganic materials 0.000 claims abstract description 6
- 235000000346 sugar Nutrition 0.000 claims description 7
- 239000003058 plasma substitute Substances 0.000 claims description 6
- 230000001737 promoting effect Effects 0.000 claims description 6
- 210000003491 skin Anatomy 0.000 abstract description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 6
- 239000008103 glucose Substances 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 6
- 229920002307 Dextran Polymers 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 3
- -1 glucose saccharide Chemical class 0.000 abstract description 3
- 102000009027 Albumins Human genes 0.000 abstract description 2
- 108010088751 Albumins Proteins 0.000 abstract description 2
- 102000008946 Fibrinogen Human genes 0.000 abstract description 2
- 108010049003 Fibrinogen Proteins 0.000 abstract description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract description 2
- 229930006000 Sucrose Natural products 0.000 abstract description 2
- 229940012952 fibrinogen Drugs 0.000 abstract description 2
- 238000009472 formulation Methods 0.000 abstract description 2
- 239000000049 pigment Substances 0.000 abstract description 2
- 239000005720 sucrose Substances 0.000 abstract description 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 2
- 230000008021 deposition Effects 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000005470 impregnation Methods 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 10
- 230000003204 osmotic effect Effects 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 201000004384 Alopecia Diseases 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 6
- 231100000360 alopecia Toxicity 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000003792 electrolyte Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 208000000069 hyperpigmentation Diseases 0.000 description 4
- 230000003810 hyperpigmentation Effects 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 230000003779 hair growth Effects 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 230000002407 ATP formation Effects 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000001700 mitochondrial membrane Anatomy 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000005061 intracellular organelle Anatomy 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60087988A JPS61246130A (ja) | 1985-04-24 | 1985-04-24 | 水性皮膚及び毛髪化粧料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60087988A JPS61246130A (ja) | 1985-04-24 | 1985-04-24 | 水性皮膚及び毛髪化粧料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61246130A true JPS61246130A (ja) | 1986-11-01 |
| JPH0212443B2 JPH0212443B2 (enExample) | 1990-03-20 |
Family
ID=13930191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60087988A Granted JPS61246130A (ja) | 1985-04-24 | 1985-04-24 | 水性皮膚及び毛髪化粧料 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61246130A (enExample) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63229068A (ja) * | 1987-03-17 | 1988-09-22 | 新技術事業団 | 電気刺激創傷治療装置 |
| JPH05117158A (ja) * | 1991-10-22 | 1993-05-14 | Sasaki Kagaku Yakuhin Kk | 皮膚外用剤組成物 |
| WO1994009750A1 (en) * | 1992-10-30 | 1994-05-11 | Unilever Plc | Cosmetic composition |
| EP0618792A4 (en) * | 1991-12-05 | 1994-12-07 | John P Alt | METHOD AND COMPOSITION FOR TREATING SKIN USEFUL FOR MITIGATING ACNE AND MALE-TYPE BALDNESS. |
| EP0780129A3 (en) * | 1995-12-11 | 2000-07-19 | CAC Corporation | Adrenal cortical steroid containing external therapeutic composition for dermatitis |
| JP2001139477A (ja) * | 1999-11-17 | 2001-05-22 | Coherent Technology:Kk | 創傷部位の組織細胞増殖促進液 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4732881B2 (ja) * | 2005-12-07 | 2011-07-27 | Ｔｔｉ・エルビュー株式会社 | イオントフォレーシス装置 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3574854A (en) * | 1966-03-22 | 1971-04-13 | Francois J Bossard | Method for soothing the skin with a cream containing sodium chloride |
| US3777597A (en) * | 1970-04-29 | 1973-12-11 | Pharmachem Corp | Method of shaving employing an aqueous solution of dextran |
| US3859436A (en) * | 1968-10-02 | 1975-01-07 | Kolmar Laboratories | Sugar composition for topical application |
-
1985
- 1985-04-24 JP JP60087988A patent/JPS61246130A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3574854A (en) * | 1966-03-22 | 1971-04-13 | Francois J Bossard | Method for soothing the skin with a cream containing sodium chloride |
| US3859436A (en) * | 1968-10-02 | 1975-01-07 | Kolmar Laboratories | Sugar composition for topical application |
| US3777597A (en) * | 1970-04-29 | 1973-12-11 | Pharmachem Corp | Method of shaving employing an aqueous solution of dextran |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63229068A (ja) * | 1987-03-17 | 1988-09-22 | 新技術事業団 | 電気刺激創傷治療装置 |
| JPH05117158A (ja) * | 1991-10-22 | 1993-05-14 | Sasaki Kagaku Yakuhin Kk | 皮膚外用剤組成物 |
| EP0618792A4 (en) * | 1991-12-05 | 1994-12-07 | John P Alt | METHOD AND COMPOSITION FOR TREATING SKIN USEFUL FOR MITIGATING ACNE AND MALE-TYPE BALDNESS. |
| WO1994009750A1 (en) * | 1992-10-30 | 1994-05-11 | Unilever Plc | Cosmetic composition |
| EP0780129A3 (en) * | 1995-12-11 | 2000-07-19 | CAC Corporation | Adrenal cortical steroid containing external therapeutic composition for dermatitis |
| JP2001139477A (ja) * | 1999-11-17 | 2001-05-22 | Coherent Technology:Kk | 創傷部位の組織細胞増殖促進液 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0212443B2 (enExample) | 1990-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2681527B2 (ja) | 細胞活性促進外用剤 | |
| US5496827A (en) | Compositions for the transdermal delivery of nutrients | |
| US20100129465A1 (en) | Methods and Compositions Related to Acne Treatment | |
| KR20040006007A (ko) | 산성 외용 조성물 및 이것을 포함하는 화장료, 육모제, 외용제용의 피부 등에의 침투 촉진제 | |
| KR100673044B1 (ko) | 경피 투여용 국소 조성물 | |
| JPH01163110A (ja) | 皮膚老化予防剤 | |
| JP3294694B2 (ja) | ヒオウギ抽出物を含有する細胞賦活剤とその応用 | |
| JPS61246130A (ja) | 水性皮膚及び毛髪化粧料 | |
| CN102228415A (zh) | 一种含有氨甲环酸的组合物、其制备方法及用途 | |
| CN109771326B (zh) | 一种用于美白修护面膜的组合物 | |
| JPH05221823A (ja) | 水性皮膚及び頭皮・頭髪化粧料 | |
| WO2003086421A1 (fr) | Preparations a usage externe renforcant l'activite cellulaire | |
| JP2000514414A (ja) | ベタインの含有を特徴とする複合製剤 | |
| US20070190173A1 (en) | Antioxidant skin compositions and methods of production of the same | |
| US10272104B2 (en) | Method for treating itch | |
| PT2004235E (pt) | Composição para uso cosmético ou farmacêutico-dermatológico | |
| WO2008041608A1 (fr) | Préparation externe cutanée et produit de soin capillaire | |
| JPH107581A (ja) | アルギナーゼ活性促進剤 | |
| US20170035802A1 (en) | Method for treating itching | |
| JP2766811B2 (ja) | 水性皮膚外用剤 | |
| EP1752132A2 (en) | Skin cosmetic compositions | |
| WO2019228060A1 (zh) | 一种深层清洁毛孔的组合物及深层清洁毛孔的方法 | |
| KR0141930B1 (ko) | 세포활성촉진 외용제 | |
| RU2325900C2 (ru) | Состав для кожи наружного применения | |
| RU2315611C1 (ru) | Биологически активная добавка к бальнеологическому средству для ванн (ее варианты) и бальнеологическое средство для ванн на ее основе |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |